| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/10/2002 | EP1220912A2 Novel human membrane proteins |
| 07/10/2002 | EP1220911A2 P-glycoproteins and uses thereof |
| 07/10/2002 | EP1220901A1 26 human secreted proteins |
| 07/10/2002 | EP1220897A1 Quiescent cell dipeptidyl peptidase: a novel cytoplasmic serine protease |
| 07/10/2002 | EP1220893A1 Medium for the protein-free and serum-free cultivation of cells |
| 07/10/2002 | EP1220865A1 43 human secreted proteins |
| 07/10/2002 | EP1220684A2 Methods related to immunostimulatory nucleic acid-induced interferon |
| 07/10/2002 | EP1220681A2 Opaminergic neuronal survival-promoting factors and uses thereof |
| 07/10/2002 | EP1220679A1 Cell-based gene therapy for the pulmonary system |
| 07/10/2002 | EP1220611A1 Suppressor cells for prevention and treatment of immune responses in transplantation |
| 07/10/2002 | EP1071446B1 Regulation of ovarian maturation and function using epidermal growth factor |
| 07/10/2002 | EP0931162A4 Production of a multimeric protein by cell fusion method |
| 07/10/2002 | CN1358230A 启动子 Promoter |
| 07/10/2002 | CN1358228A Polynucleotide and deduced amino acid sequences from stromal cells |
| 07/10/2002 | CN1358197A Compositions and methods for cancer treatment by selectively inhibiting VEGF |
| 07/10/2002 | CN1358076A Personal cervical cell collector |
| 07/10/2002 | CN1357621A Establishing method of active cell strain for quantitative determination of bone morphogenetic protein (BMP) |
| 07/10/2002 | CN1357620A Hemapoietic stem/ancestral cell enriching method and its in vitro directional induction and differentiation |
| 07/10/2002 | CN1087346C RANTFS peptide and fragments for treatment of inflammation, and compositions with them |
| 07/09/2002 | US6417429 Genetic engineering |
| 07/09/2002 | US6417333 Modified human parathyroid hormone |
| 07/09/2002 | US6417328 Isolated genes encoding tumor necrosis factor-related apotosis-inducing ligand (trail) receptor splice variant cdna sequences, or active fragment; immunogens, modulation therapeutic autoimmune diseases, aids |
| 07/09/2002 | US6417002 Method for maintenance and selection of episomes |
| 07/09/2002 | US6417001 Embryogenesis process for initiation |
| 07/09/2002 | US6416999 Cell differentiation |
| 07/09/2002 | US6416998 Polypeptides |
| 07/09/2002 | US6416991 Genetic engineered protein |
| 07/09/2002 | US6416986 Converts 4-chloroacetoacetate ester to (s)-4-halo-3-hydroxy butyrate; does not substantially dehydrogenate optical isomers of 4-halo-3-hydroxy-butyrate ester; uses reduced beta-nicotinamide adenine dinucleotide as electron donor |
| 07/09/2002 | US6416984 Human DNA mismatch repair proteins |
| 07/09/2002 | US6416980 Method for producing glycolic acid from glycolonitrile using nitrilase |
| 07/09/2002 | US6416975 Human glycine transporter type 2 |
| 07/09/2002 | US6416974 Tango 71 nucleic acids |
| 07/09/2002 | US6416972 Purified hybrid nucleic acid |
| 07/09/2002 | US6416959 Providing cells containing luminescent reporter molecules in array of locations, treating with reagents, imaging numerous cells in each location, converting signals into digital data, determining distribution, environment or activity |
| 07/09/2002 | US6416958 Antibody binds an epitope on the hla-dr polypeptide and induces apoptosis in cells expressing hla-dr, without concomitant suppression of hla-dr dependent immune responses. |
| 07/09/2002 | US6416956 Screening for and/or diagnosing breast cancer by obtaining cell sample from patient and determining whether bp1 is overexpressed by said cell sample as compared to normal cells |
| 07/09/2002 | US6416758 Antibody conjugate kits for selectively inhibiting VEGF |
| 07/09/2002 | CA2264189C Homocysteine desulphurase from the protozoan trichomonas vaginalis |
| 07/09/2002 | CA2182367C Density gradient medium for separating cells |
| 07/09/2002 | CA2133845C Adrenocorticotrophic hormone receptor and uses |
| 07/09/2002 | CA2077434C Antigenic proteins of borrelia burgdorferi |
| 07/08/2002 | CA2365925A1 Method of separating cells from a sample |
| 07/04/2002 | WO2002052273A1 Screening method based on siah-numb interaction |
| 07/04/2002 | WO2002052039A2 Methods for selecting and producing pharmaceutical compounds using a library responsive to transcription factors |
| 07/04/2002 | WO2002052023A2 Position-independent and tissue specific expression of a transgene in milk of transgenic animals |
| 07/04/2002 | WO2002052018A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/04/2002 | WO2002052017A1 Process for producing coenzyme q¿10? |
| 07/04/2002 | WO2002052015A2 Self-replicating rna molecule from hepatitis c virus |
| 07/04/2002 | WO2002052014A2 Efficient expression of plasmodium apical membrane antigen 1 in yeast cells |
| 07/04/2002 | WO2002052012A2 Sugar beet genes involved in stress tolerance |
| 07/04/2002 | WO2002052009A1 Human fgf23 protein mutant lowering blood phosphorus level |
| 07/04/2002 | WO2002052004A1 Gene involved in apoptosis regulation |
| 07/04/2002 | WO2002051994A2 Polypeptides |
| 07/04/2002 | WO2002051988A2 Thymic epithelial progenitor cells and uses thereof |
| 07/04/2002 | WO2002051987A1 System for the cell-specific and development-specific selection of differentiating embryonic stem cells, adult stem cells and embryonic germline cells |
| 07/04/2002 | WO2002051986A2 Educated nk t cells and their uses in the treatment of immune-related disorders |
| 07/04/2002 | WO2002051985A2 Culturing tissue using magnetically generated mechanical stresses |
| 07/04/2002 | WO2002051980A2 In vitro-derived adult pluripotent stem cells and uses therefor |
| 07/04/2002 | WO2002051871A2 Anti-cd28 antibody |
| 07/04/2002 | WO2002051868A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 07/04/2002 | WO2002051864A1 Protein cluster ii |
| 07/04/2002 | WO2002051433A2 Use of artemin, a member of the gdnf ligand family for preparing a neuroprotective medicament |
| 07/04/2002 | WO2002051430A2 Methods of modulating toll-related receptor (trr) signaling |
| 07/04/2002 | WO2002051355A2 Acetyl-coenzyme a carboxylase 2 as a target in fat regulation and insulin action |
| 07/04/2002 | WO2002051237A2 Helicobacter proteins, nucleic acids and uses thereof |
| 07/04/2002 | WO2002033100A3 Regulation of human adenylate cyclase, type iv |
| 07/04/2002 | WO2002026988A9 Human drug metabolizing enzymes |
| 07/04/2002 | WO2002023202A8 Method to identify antibody targets based on mass spectrometry (maldi-tof) |
| 07/04/2002 | WO2002012274A3 Iapl-3 a protein inhibitor of apoptosis proteins |
| 07/04/2002 | WO2002009790A8 Collagen membrane arranged at macromolecular level |
| 07/04/2002 | WO2002002624A3 B7-like molecules and uses thereof |
| 07/04/2002 | WO2002000677A8 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001098517A3 Cost effective media for large scale insect cell culture |
| 07/04/2002 | WO2001096532A3 Method of generating pluripotent mammalian cells by fusion of a cytoplast fragment with a karyoplast |
| 07/04/2002 | WO2001092492A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/04/2002 | WO2001090148A8 Neurotransmitter transporters |
| 07/04/2002 | WO2001085974A3 Retroviral vectors comprising an enhanced 3' transcription termination structure |
| 07/04/2002 | WO2001083563A3 Method of identifying agents that alter the activity of the promoter sequence for crf receptor 2-alpha |
| 07/04/2002 | WO2001077298A3 Human müllerian duct-derived epithelial cells and methods of isolation and uses thereof |
| 07/04/2002 | WO2001077169A3 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 07/04/2002 | WO2001076507A3 Use of oxygen carriers to improve grafted cell survival in neural transplantation |
| 07/04/2002 | WO2001072954A3 Perfusion incubator |
| 07/04/2002 | WO2001068855A3 Gtp-binding protein gamma-12 subunit |
| 07/04/2002 | WO2001059089A3 Improved galactosylation of recombinant glycoproteins |
| 07/04/2002 | WO2001057207A3 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 07/04/2002 | WO2001041791A9 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 07/04/2002 | WO2001036589A9 Human ex vivo immune system |
| 07/04/2002 | WO2001032841A9 Method of in vitro t cell differentiation of cd34+ progenitor cells |
| 07/04/2002 | WO2001032673A9 Sequences encoding human neoplastic marker |
| 07/04/2002 | WO2001032189A9 Supernatant from mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| 07/04/2002 | WO2000069897A9 Modulation of glgf motif (dhr/pdz) containing proteins interaction with cd3n in t lymphocytes |
| 07/04/2002 | WO2000069891A9 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins |
| 07/04/2002 | WO2000068396A9 Bacillus circulans xylanase mutants |
| 07/04/2002 | US20020088027 Expression of biologically active polypeptides in duckweed |
| 07/04/2002 | US20020088023 Nucleotide sequences coding enzymatic protein for use in generating plants with amplified starch biosynthesis |
| 07/04/2002 | US20020088018 Transgenic mice containing MAS orphan receptor gene disruptions |
| 07/04/2002 | US20020087214 In vitro engineered, regenerated urinary tract tissue compositions and methods for producing same |
| 07/04/2002 | US20020087096 Personal cervical cell collector |
| 07/04/2002 | US20020086987 Nucleotide sequence coding human protein for use in treatment of osteoporosis and bone disorders |
| 07/04/2002 | US20020086979 Reagents and methods useful for detecting diseases of the breast |